Based on the above results, we found that chidamide could enhance the immune cell‐mediated anti‐tumor effect of PD‐1 (+) cells, so we further explored the changes of gene expression in PD‐1 (+) cells from PTCL patients prior and post treatment of chidamide. Here, PDCD1 is linked to neoplasm.